Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,182,845 papers from all fields of science
Search
Sign In
Create Free Account
Dideaza-5,6,7,8-Tetrahydrofolic Acid
Known as:
DDATHF
An antimetabolite and folate analogue with anti-proliferative activity. Dideazatetrahydrofolic acid inhibits activity of glycinamide ribonucleotide…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Lometrexol
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
A Phase I clinical study of the antipurine antifolate lometrexol (DDATHF) given with oral folic acid
S. Laohavinij
,
S. Wedge
,
+13 authors
A. Calvert
Investigational new drugs
2004
Corpus ID: 23915783
SummaryLometrexol is an antifolate which inhibits glycinamide ribonucleotide formyltransferase (GARFT), an enzyme essential for…
Expand
Review
2004
Review
2004
Biological and biochemical properties of new anticancer folate antagonists
D. W. Fry
,
R. Jackson
Cancer Metastasis Review
2004
Corpus ID: 20492765
SummaryWe review the biology and biochemical pharmacology of four antifolates that were recently introduced into clinical trial…
Expand
Highly Cited
2002
Highly Cited
2002
Multiple mechanisms of resistance to methotrexate and novel antifolates in human CCRF-CEM leukemia cells and their implications for folate homeostasis.
R. Mauritz
,
G. Peters
,
+9 authors
G. Jansen
Biochemical Pharmacology
2002
Corpus ID: 25910818
2000
2000
Sensitivity to 5,10-dideazatetrahydrofolate is fully conserved in a murine leukemia cell line highly resistant to methotrexate due to impaired transport mediated by the reduced folate carrier.
R. Zhao
,
F. Gao
,
S. Babani
,
I. Goldman
Clinical Cancer Research
2000
Corpus ID: 12058517
A murine leukemia cell line was identified that is highly resistant to methotrexate (MTX), due to impaired transport, but fully…
Expand
1995
1995
5,10-Dideazatetrahydrofolic acid reduces toxicity and deoxyadenosine triphosphate pool, expansion in cultured L1210 cells treated with inhibitors of thymidylate synthase.
L. K. Chong
,
M. Tattersall
Biochemical Pharmacology
1995
Corpus ID: 46505793
Highly Cited
1994
Highly Cited
1994
Impact of dietary folic acid on reduced folates in mouse plasma and tissues. Relationship to dideazatetrahydrofolate sensitivity.
John C. Schmitz
,
Grindey Gb
,
Schultz Rm
,
David G. Priest
Biochemical Pharmacology
1994
Corpus ID: 24126474
1994
1994
Mechanism of cytotoxicity of 5,10-dideazatetrahydrofolic acid in human ovarian carcinoma cells in vitro and modulation of the drug activity by folic or folinic acid.
Eugenio Erba
,
Soumitra Sen
,
Cristiana Sessa
,
F. Vikhanskaya
,
Maurizio D'Incalci
British Journal of Cancer
1994
Corpus ID: 9155431
Inhibition of clonogenic potential by the glycinamideribonucleosyl transformylase inhibitor 5,10-dideazatetrahydrofolic acid…
Expand
1993
1993
Cytotoxicity of antifolate inhibitors of thymidylate and purine synthesis to WiDr colonic carcinoma cells.
S. Smith
,
N. Lehman
,
R. Moran
Cancer Research
1993
Corpus ID: 14198247
We have studied the cytotoxicity of 5,10-dideazatetrahydrofolate (DDATHF) and of D-1694 to human WiDr colonic carcinoma cells as…
Expand
Highly Cited
1991
Highly Cited
1991
Structural features of 5,10-dideaza-5,6,7,8-tetrahydrofolate that determine inhibition of mammalian glycinamide ribonucleotide formyltransferase.
Samuel W. Baldwin
,
A. Tse
,
+4 authors
R. Moran
Biochemistry
1991
Corpus ID: 24216851
We have investigated the structural features of 5,10-dideaza-5,6,7,8-tetrahydrofolate (DDATHF) that determine the activity of…
Expand
1988
1988
Synthesis and biological properties of 5,10-dideaza-5,6,7,8-tetrahydrofolic acid.
D. Boschelli
,
S. Webber
,
J. Whiteley
,
A. Oronsky
,
S. Kerwar
Archives of Biochemistry and Biophysics
1988
Corpus ID: 24186237
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE